MAT Training for Opioid Addiction Waiver

MAT Training for Opioid Addiction Waiver


April 18, 2020 ? 1:00 PM – 5:00 PM
Medication Assisted Treatment (MAT) Training for Opioid Addiction Waiver In-Person*

  • ‘Half and Half’ Training, i.e. half online & half in-person
  • Developed for the American Academy for Addiction Psychiatry

This course is suitable for providers who would like to obtain a waiver for their DEA license to prescribe buprenorphine products for opiate use disorder. The course is offered with a compulsory online component and 4 hours in person training. Note that the urine testing also encompasses the education of other drug tests such as a hair follicle test as well as others.

Modules Covered in the Course:

  • Overview: Opioid Use Disorder Treatment with Buprenorphine/Naloxone (0.5 hours)
  • Patient Evaluation (0.75 hours)
  • Specialty Topics (0.75 hours)
  • Case Study #1 (0.25 hours)
  • Medication Assisted Treatment Clinical Application (0.5 hours)
  • Case Study #2 (0.25 hours)
  • Urine Drug Testing (0.5 hours)
  • Case Study #3 (0.25 hours)
  • Overview of Clinical Tools (0.25 hours)
  • Completing the Notification of Intent Waiver Form (0.25 hours)


Following completion of the in-person training, the AACP will send a link to the online training half. There will be three modules to review followed by a 20 question exam. Once the exam is passed, a Certificate of Completion will be provide with instructions on applying for the waiver. On line training must be completed within 30 days of receiving the link.

NPs/PAs can take the 8 hour waiver training and it will count towards their waiver application. The additional 16 hours of training is available on PCSS at no cost:

Residents can take the waiver training; they will not be able to apply until they have a personal DEA number and an unrestricted medical license.

This activity has been approved for AMA PRA Category 1 Credit™
This activity will be certified for ANCC contact hours
(including pharmacotherapeutic contact hours) and will award
AAPA Category 1 CME credit.

Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services? nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

American Academy of Addiction Psychiatry (AAAP) is the Data Sponsor for this training.

Cost: $50.00
Registration: Click here to register and view complete activity information

Target Audience:
• Physicians
• Nurse Practitioners
• Physician Assistants


In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and the American Conference for the Treatment of HIV (ACTHIV). American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Academy of CME, Inc. designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of CME, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

American Academy of CME, Inc. designates this educational activity for 4.0 contact hours (4.0 pharmacotherapeutic contact hours).

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Disclosure Declaration:
According to the disclosure policy of Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures will be made known to the participants prior to the activity.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, ACTHIV, or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.